BRPI0917503B8 - composição de ferro férrico para uso em um método de tratamento de hiperfosfatemia, bem como fluido de diálise e método ex vivo para remoção de fosfato de meio - Google Patents
composição de ferro férrico para uso em um método de tratamento de hiperfosfatemia, bem como fluido de diálise e método ex vivo para remoção de fosfato de meioInfo
- Publication number
- BRPI0917503B8 BRPI0917503B8 BRPI0917503A BRPI0917503A BRPI0917503B8 BR PI0917503 B8 BRPI0917503 B8 BR PI0917503B8 BR PI0917503 A BRPI0917503 A BR PI0917503A BR PI0917503 A BRPI0917503 A BR PI0917503A BR PI0917503 B8 BRPI0917503 B8 BR PI0917503B8
- Authority
- BR
- Brazil
- Prior art keywords
- ferric iron
- medium
- well
- dialysis fluid
- iron composition
- Prior art date
Links
- VTLYFUHAOXGGBS-UHFFFAOYSA-N Fe3+ Chemical compound [Fe+3] VTLYFUHAOXGGBS-UHFFFAOYSA-N 0.000 title abstract 2
- 229910019142 PO4 Inorganic materials 0.000 title abstract 2
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 title abstract 2
- 239000010452 phosphate Substances 0.000 title abstract 2
- 238000000034 method Methods 0.000 title 2
- 239000000385 dialysis solution Substances 0.000 title 1
- 201000005991 hyperphosphatemia Diseases 0.000 title 1
- 239000000463 material Substances 0.000 abstract 4
- 102000006335 Phosphate-Binding Proteins Human genes 0.000 abstract 2
- 108010058514 Phosphate-Binding Proteins Proteins 0.000 abstract 2
- 239000011230 binding agent Substances 0.000 abstract 2
- 150000001732 carboxylic acid derivatives Chemical group 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/26—Cyanate or isocyanate esters; Thiocyanate or isothiocyanate esters
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/20—Removal of unwanted matter, e.g. deodorisation or detoxification
- A23L5/27—Removal of unwanted matter, e.g. deodorisation or detoxification by chemical treatment, by adsorption or by absorption
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/04—Chelating agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/015—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/03—Organic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/295—Iron group metal compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/02—Iron compounds
- C07F15/025—Iron compounds without a metal-carbon linkage
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Mycology (AREA)
- Physical Education & Sports Medicine (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Toxicology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- External Artificial Organs (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
materiais de ligação ao fosfato e seus usos são apresentados materiais de ligação ao fosfato e composições compreendendo os mesmos, os quais são materiais iônicos metálicos polioxo-hidróxi modificados por ligante sólido, tendo como base oxo-hidróxidos de ferro férrico modificados com ligantes de ácido carboxílico, ou formas ionizadas do mesmo. esses materiais são produzidos e testados nos exemplos fornecidos no pedido a fim de demonstrar que podem ligar-se ao fosfato em testes in vitro e in vivo.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8624408P | 2008-08-05 | 2008-08-05 | |
US61/086.244 | 2008-08-05 | ||
GB08143265 | 2008-08-05 | ||
GBGB0814326.5A GB0814326D0 (en) | 2008-08-05 | 2008-08-05 | Phosphate binding materials and their uses |
PCT/GB2009/001931 WO2010015827A2 (en) | 2008-08-05 | 2009-08-05 | Phosphate binding materials and their uses |
Publications (3)
Publication Number | Publication Date |
---|---|
BRPI0917503A2 BRPI0917503A2 (pt) | 2015-11-17 |
BRPI0917503B1 BRPI0917503B1 (pt) | 2021-01-05 |
BRPI0917503B8 true BRPI0917503B8 (pt) | 2021-05-25 |
Family
ID=39767560
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0917503A BRPI0917503B8 (pt) | 2008-08-05 | 2009-08-05 | composição de ferro férrico para uso em um método de tratamento de hiperfosfatemia, bem como fluido de diálise e método ex vivo para remoção de fosfato de meio |
Country Status (21)
Country | Link |
---|---|
US (1) | US7943664B2 (pt) |
EP (1) | EP2320884B1 (pt) |
JP (2) | JP5805532B2 (pt) |
KR (1) | KR101653423B1 (pt) |
CN (1) | CN102143742B (pt) |
AU (1) | AU2009278906B9 (pt) |
BR (1) | BRPI0917503B8 (pt) |
CA (1) | CA2732226C (pt) |
EA (1) | EA021705B1 (pt) |
ES (1) | ES2592315T3 (pt) |
GB (2) | GB0814326D0 (pt) |
HU (1) | HUE029874T2 (pt) |
IL (1) | IL210913A (pt) |
LT (1) | LT2320884T (pt) |
MX (1) | MX2011001258A (pt) |
PL (1) | PL2320884T3 (pt) |
PT (1) | PT2320884T (pt) |
SI (1) | SI2320884T1 (pt) |
SM (1) | SMT201600359B (pt) |
WO (1) | WO2010015827A2 (pt) |
ZA (1) | ZA201100821B (pt) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2008212653B2 (en) * | 2007-02-06 | 2012-05-24 | United Kingdom Research And Innovation | Ligand modified poly oxo-hydroxy metal ion materials, their uses and processes for their preparation |
TWI468167B (zh) | 2007-11-16 | 2015-01-11 | 威佛(國際)股份有限公司 | 藥學組成物 |
JP2013520647A (ja) * | 2010-02-19 | 2013-06-06 | ジーイー・ヘルスケア・バイオサイエンス・アクチボラグ | クロマトグラフィー媒体の製造方法 |
GB201101299D0 (en) | 2011-01-25 | 2011-03-09 | Medical Res Council | Oxygen sensors and their uses |
WO2013027214A2 (en) | 2011-08-22 | 2013-02-28 | Bar-Ilan University | Nanop article dialysis |
US9370202B2 (en) | 2013-03-15 | 2016-06-21 | LG Bionano, LLC | Encapsulated metal ion nanoclusters |
RS60894B1 (sr) | 2013-11-27 | 2020-11-30 | Vifor Int Ag | Farmaceutska kompozicija, koja sadrži čestice vezivnog sredstva za fosfat |
EP3191219A1 (en) * | 2014-09-10 | 2017-07-19 | Lupin Limited | A manufacturing process for an iron containing adsorbent |
GB201517893D0 (en) * | 2015-10-09 | 2015-11-25 | Medical Res Council | Methods for producing carboxylate ligand modified ferric iron hydroxide colloids |
WO2017145151A1 (en) * | 2016-02-23 | 2017-08-31 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Process for preparation of nicotinamide riboside (nr) and cosmetic composition comprising (nr and a phosphate-binding agent |
US11136251B2 (en) | 2017-03-23 | 2021-10-05 | Regents Of The University Of Minnesota | Compositions, methods, and devices for capturing phosphate from water |
CN114797781B (zh) * | 2022-06-07 | 2022-12-06 | 广东粤海水务投资有限公司 | 一种载镧氮掺杂多孔碳磷吸附材料的制备方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT279048B (de) * | 1967-07-04 | 1970-02-25 | Pharmazeutische Fabrik Montavit Gmbh | Verfahren zur Herstellung neuer, löslicher und stabiler organischer Eisen(III)-Komplexverbindungen und Injektionslösungen davon |
DE4239442C2 (de) * | 1992-11-24 | 2001-09-13 | Sebo Gmbh | Verwendung eines mit polynuklearen Metalloxidhydroxiden modifizierten Adsorptionsmaterials zur selektiven Elimination von anorganischem Phosphat aus proteinhaltigen Flüssigkeiten |
DE19547356A1 (de) * | 1995-12-19 | 1997-06-26 | Vifor Int Ag | Adsorbens für Phosphat aus wäßrigem Medium, dessen Herstellung und Verwendung |
TWI335218B (en) * | 2003-02-19 | 2011-01-01 | Panion & Bf Biotech Inc | Ferric organic compounds, uses thereof and methods of making same |
US6903235B2 (en) | 2003-10-08 | 2005-06-07 | Panion & Bf Biotech Inc. | Pharmaceutical-grade ferric citrate |
MY157620A (en) | 2006-01-31 | 2016-06-30 | Cytochroma Dev Inc | A granular material of a solid water-soluble mixed metal compound capable of binding phosphate |
PT2319804E (pt) | 2006-12-14 | 2014-11-24 | Novartis Ag | Adsorvente de fosfato à base de ferro (iii)-carboidrato |
AU2008212653B2 (en) | 2007-02-06 | 2012-05-24 | United Kingdom Research And Innovation | Ligand modified poly oxo-hydroxy metal ion materials, their uses and processes for their preparation |
GB0702270D0 (en) * | 2007-02-06 | 2007-03-14 | Medical Res Council | Ligand modified poly oxo-hydroxy metal ion materials, their uses and processes for their preparation |
TWI468167B (zh) * | 2007-11-16 | 2015-01-11 | 威佛(國際)股份有限公司 | 藥學組成物 |
-
2008
- 2008-08-05 GB GBGB0814326.5A patent/GB0814326D0/en not_active Ceased
-
2009
- 2009-08-05 HU HUE09784878A patent/HUE029874T2/en unknown
- 2009-08-05 BR BRPI0917503A patent/BRPI0917503B8/pt active IP Right Grant
- 2009-08-05 GB GB0913684A patent/GB2462374B/en active Active
- 2009-08-05 LT LTEP09784878.2T patent/LT2320884T/lt unknown
- 2009-08-05 MX MX2011001258A patent/MX2011001258A/es active IP Right Grant
- 2009-08-05 CA CA2732226A patent/CA2732226C/en active Active
- 2009-08-05 ES ES09784878.2T patent/ES2592315T3/es active Active
- 2009-08-05 PL PL09784878T patent/PL2320884T3/pl unknown
- 2009-08-05 JP JP2011521635A patent/JP5805532B2/ja active Active
- 2009-08-05 US US12/536,014 patent/US7943664B2/en active Active
- 2009-08-05 AU AU2009278906A patent/AU2009278906B9/en active Active
- 2009-08-05 SI SI200931533A patent/SI2320884T1/sl unknown
- 2009-08-05 CN CN200980134870.5A patent/CN102143742B/zh active Active
- 2009-08-05 EA EA201170116A patent/EA021705B1/ru unknown
- 2009-08-05 EP EP09784878.2A patent/EP2320884B1/en active Active
- 2009-08-05 KR KR1020117004981A patent/KR101653423B1/ko active IP Right Grant
- 2009-08-05 PT PT97848782T patent/PT2320884T/pt unknown
- 2009-08-05 WO PCT/GB2009/001931 patent/WO2010015827A2/en active Application Filing
-
2011
- 2011-01-27 IL IL210913A patent/IL210913A/en active IP Right Grant
- 2011-02-01 ZA ZA2011/00821A patent/ZA201100821B/en unknown
-
2014
- 2014-06-10 JP JP2014119953A patent/JP2014205689A/ja active Pending
-
2016
- 2016-10-07 SM SM201600359T patent/SMT201600359B/it unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0917503B8 (pt) | composição de ferro férrico para uso em um método de tratamento de hiperfosfatemia, bem como fluido de diálise e método ex vivo para remoção de fosfato de meio | |
BR112012019693A2 (pt) | anticorpos que se ligam à lisil oxidase-like 2 (loxl2) e métodos de uso para eles. | |
BRPI1013688A8 (pt) | Proteínas de ligação de il-17. | |
WO2016100976A3 (en) | Methods for identifying multiple epitopes in selected sub-populations of cells | |
CL2016002340A1 (es) | Proteínas de unión al antígeno cd27l; ácido nucleico que la codifica; vector de expresión; célula huésped recombinante; composición que la comprende; su uso para tratar cáncer, trastornos autoinmunitarios o inflamatorios; y método para elaborar un conjugado anticuerpo cd27l-fármaco (divisional sol. n° 699-14). | |
WO2006117596A3 (en) | Nucleic acid probes and nucleic acid analog probes | |
EA201000146A1 (ru) | Связующее майларда на основе гидроксимонокарбоновой кислоты | |
BR112012033091A2 (pt) | método de cimentação, e, composição de cimento | |
BRPI0519897A2 (pt) | método para modular a atividade ou atividades biológicas de moléculas alvo em uma célula alvo, agente de ligação biespecìfico, composição, uso de um agente de ligação biespecìfico, e, kit | |
AR066395A1 (es) | Reovirus que tienen secuencias modificadas | |
BRPI0918670B8 (pt) | anticorpo | |
BRPI0907663A2 (pt) | ''composição que compreende hfo- 123 yf, composição que compreende hcfc-243db, composição que compreende hcfo- 1233xf, composição que comproeende hcfc- 244bb, uso das composições e método de uso das composições. | |
AR060583A1 (es) | Anticuerpo de c- kit humanizado | |
AR069980A1 (es) | Inmunoconjugados dirigidos contra cd 138 y sus usos | |
BR112014012121A2 (pt) | proteínas ligantes | |
BRPI0906478B8 (pt) | anticorpo anti-nr10, seu uso e composição farmacêutica que o compreende | |
BRPI0807132A2 (pt) | enzimas para o tratamento de lignocelulósicos, ácidos nucléicos que codificam as mesmas, e metodos e uso das mesmas | |
BR112013014238A2 (pt) | processo para tratar uma formação subterrânea, fluido adequado para uso no processo e sal de amônio da fórmula mx(nh4)yhz-glda ou da fórmula mx(nh4)yhz-mgda | |
AR088513A1 (es) | Inmunoenlazantes dirigidos contra esclerostina | |
BRPI0814343A2 (pt) | Materiais e métodos para a seleção da sexagem do esperma | |
CO6351748A2 (es) | Anticuerpos contra il-6 y sus usos | |
GB201020995D0 (en) | Biological materials and uses thereof | |
BR112013003825A2 (pt) | conjugados, partículas, composições e métodos relacionados | |
AR064301A1 (es) | Absorbente de fosfato basado en hierro (iii) | |
NI201000055A (es) | 2' - fluoro - 2' - desoxitetrahidrouridinas como inhibidores de citidina desaminasa. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B15K | Others concerning applications: alteration of classification |
Ipc: A61K 31/26 (2006.01), A23L 5/20 (2016.01), A23L 29 |
|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B25A | Requested transfer of rights approved |
Owner name: UNITED KINGDOM RESEARCH AND INNOVATION (GB) |
|
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 05/01/2021, OBSERVADAS AS CONDICOES LEGAIS. |
|
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 05/08/2009 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |